The concentration of cfDNA was comparable in the two BrCa subtypes (mean HER2+: 3.9 ng/mL; mean HER2‐:2.9 ng/mL) within the early‐stage cohort (Figure 2e and Figure S3f). Here, ERBB2 is linked to invasive breast carcinoma.